Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal

Related Experiment Video

Updated: Jul 19, 2026

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

Nina M Muñoz1, Melissa Upton, Andres Rojas

  • 1Department of Cancer Biology, Vanderbilt University Medical School, Nashville, Tennessee, USA.

Cancer Research
|October 19, 2006
PubMed

Insights

Inactivating the TGF-beta receptor 2 (TGFBR2) in colon cancer promotes tumor growth and spread. This study shows that TGFBR2 loss cooperates with Apc mutations to drive intestinal cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The transforming growth factor-beta (TGF-beta) pathway acts as a tumor suppressor and is frequently inactivated in colon cancer.
  • Mutations in the TGF-beta receptor type II (TGFBR2) gene are found in approximately 30% of colon cancers, indicating its critical role.

Purpose of the Study:

  • To investigate the functional impact of TGFBR2 inactivation on the development and progression of colon cancer.
  • To elucidate the cooperative mechanisms between Wnt signaling (Apc mutation) and TGF-beta signaling (TGFBR2 inactivation) in intestinal tumorigenesis.

Main Methods:

  • Generation of a novel mouse model (Apc(1638N/wt);Tgfbr2(IEKO)) by combining Apc mutation with intestinal epithelial-specific Tgfbr2 deletion.
  • In vitro analysis of tumor cells for matrix metalloproteinase (MMP) expression and activity, and TGF-beta1 secretion.
  • In vivo assessment of tumor characteristics and molecular markers in the generated mouse model.

Main Results:

  • The Apc(1638N/wt);Tgfbr2(IEKO) mice exhibited a significant increase in intestinal adenocarcinomas compared to controls.
  • Loss of TGFBR2 led to enhanced expression and activity of MMP-2 and MMP-9 in tumor cells.
  • Elevated levels of TGF-beta1 and increased MMP-2 activity were observed in tumors from Apc(1638N/wt);Tgfbr2(IEKO) mice.

Conclusions:

  • TGFBR2 inactivation in intestinal epithelial cells promotes tumor invasion and malignant transformation initiated by Apc mutations.
  • Wnt signaling deregulation and TGF-beta signaling inactivation cooperate to drive intestinal cancer initiation and progression.
  • This mouse model provides valuable insights into the molecular mechanisms underlying colon cancer development.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...